Phil Nadeau
Stock Analyst at TD Cowen
(3.65)
# 907
Out of 4,412 analysts
15
Total ratings
56.25%
Success rate
45.94%
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Outperform | $360 → $370 | $397.48 | -6.91% | 6 | Aug 2, 2023 | |
| ELVN Enliven Therapeutics | Initiates: Outperform | n/a | $17.18 | - | 1 | Mar 3, 2023 | |
| BIIB Biogen | Maintains: Outperform | $300 → $315 | $208.90 | +50.79% | 4 | Feb 16, 2023 | |
| MLTX MoonLake Immunotherapeutics | Initiates: Outperform | n/a | $42.49 | - | 1 | Jul 7, 2022 | |
| AURA Aura Biosciences | Initiates: Outperform | n/a | $7.22 | - | 1 | Nov 23, 2021 | |
| ANNX Annexon | Initiates: Outperform | n/a | $4.70 | - | 1 | Aug 18, 2020 | |
| RYTM Rhythm Pharmaceuticals | Initiates: Outperform | n/a | $38.28 | - | 1 | Oct 30, 2017 |
Vertex Pharmaceuticals
Aug 2, 2023
Maintains: Outperform
Price Target: $360 → $370
Current: $397.48
Upside: -6.91%
Enliven Therapeutics
Mar 3, 2023
Initiates: Outperform
Price Target: n/a
Current: $17.18
Upside: -
Biogen
Feb 16, 2023
Maintains: Outperform
Price Target: $300 → $315
Current: $208.90
Upside: +50.79%
MoonLake Immunotherapeutics
Jul 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $42.49
Upside: -
Aura Biosciences
Nov 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.22
Upside: -
Annexon
Aug 18, 2020
Initiates: Outperform
Price Target: n/a
Current: $4.70
Upside: -
Rhythm Pharmaceuticals
Oct 30, 2017
Initiates: Outperform
Price Target: n/a
Current: $38.28
Upside: -